Nkarta, Inc. Other Current Assets
Nkarta, Inc. (NKTX) had Other Current Assets of $2.41 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-03-25
- 2025-12-31: Other Assets, Current $2.41M.
- 2024-12-31: Other Assets, Current $2.73M.
- 2023-12-31: Other Assets, Current $1.62M.
- 2023-09-30: Other Assets, Current $1.59M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $2.41M 10-K · filed 2026-03-25 | |
| 2024-12-31 | $2.73M 10-K · filed 2026-03-25 | |
| 2023-12-31 | $1.62M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $1.59M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.59M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.37M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.93M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $3.43M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.08M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.28M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $3.15M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $2.43M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.71M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.08M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.34M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $592.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $24.52K 10-Q · filed 2020-08-20 | |
| 2019-12-31 | $67.00K 10-K · filed 2021-03-25 | $66.51K 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |